Recall archive / FDA company announcement
Lipofit: Lipofit Extreme 2.0 Fat Burner Dietary Supplement — FDA announcement Aug 31, 2026
Published notice; closure not supplied
A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.
Source date Aug 31, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Lipofit Extreme 2.0 Fat Burner Dietary Supplement
- Reason
- Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
- Classification
- Not supplied
- Recalling firm
- Ana Salazar Modela Tu Cuerpo Inc.
- Quantity
- Not supplied
- Agency-reported status
- Company recall announcement
- Source record identifier
- 28c5c23965be5a38
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | FOR IMMEDIATE RELEASE - August 27, 2026 - Davie, Florida – Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0, Lot 25M12F, expiration date 09/2027, to the consumer level. The Food and Drug Administration (FDA) laboratory analysis has found Lipofit Extreme Fat Burner 2.0 to be tainted with undeclared fluoxetine in the daytime (AM) tablets and undeclared 2,4-dinitrophenol (DNP) in the nighttime (PM) tablets. Fluoxetine is an active ingredient in an FDA-approved drug used to treat conditions including depression, bulimia and obsessive-compulsive disorder. 2,4-Dinitrophenol (DNP) is a toxic substance (commonly used as a pesticide, dye, wood preservative and herbicide) that is illegally marketed as a weight-loss product and is not approved by the FDA for any use. Products containing fluoxetine and DNP cannot be marketed as dietary supplements. Lipofit Extreme Fat Burner 2.0 is an unapproved new drug for which safety and efficacy have not been established and, therefore, subject to recall.; The tainted Lipofit Extreme Fat Burner 2.0 is marketed as a dietary supplement and is packaged as AM and PM tablets. The recalled product is identified as Lot 25M12F, expiration date 09/2027. |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
The product was distributed in the United States directly to individual consumers through online sales.
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Fda listing date
- Aug 31, 2026
- Company announcement date
- Aug 27, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.